Follow
Cancer
Cancer: is a disease in which abnormal cells divide uncontrollably and destroy body tissue. Cancerous tumors are malignant, which means they can spread into, or invade, nearby tissues.
MAY 14, 2025 | 11:00 AM
Interpreting genomic test results for cancer care remains a significant challenge, with variability in turnaround times, reporting standards, and clinical utility impacting patient outcomes....
On Demand
LGC offers a comprehensive portfolio of reference standards and scientific tools for a wide range of disciplines. The focus of this talk will be on reference materials for clinical NGS produ...
MAY 13, 2025 | 9:00 AM
Immune checkpoint blockade (ICB) targeting T cells has enhanced clinical outcomes in patients with renal and bladder cancers; however, response rates remain limited, particularly in cases of...
On Demand
C.E. CREDITS
Clinical effectiveness of immune therapies of solid tumors requires a) the induction or expansion of T cells able of recognizing multiple variants of cancer cells present in each cancer pati...
APR 23, 2025 | 9:00 AM
This podcast delves into the innovative role of Dynabeads magnetic beads for mRNA synthesis and purification in the personalized mRNA therapeutic field. It introduces the concept of using Dy...
APR 23, 2025 | 1:00 AM
Finding the right predictive and prognostic biomarkers is essential for improving cancer treatment. In this 30 min webinar, we’ll explore how NGS proteomics, combined with genomics , p...
APR 17, 2025 | 8:00 AM
This webinar explores cutting-edge advancements in ultra-deep circulating tumor DNA (ctDNA) sequencing, integrating artificial intelligence (AI) and precision oncology to address critical ch...
APR 08, 2025 | 8:00 AM
Fluorescence imaging offers robust, multi-parametric and scalable analysis of celllevel activity in heterogenous populations with excellent spatial and temporal resolution. This seminar will...
MAR 26, 2025 | 8:00 AM
Single-cell analysis is a new and rapidly growing field that is shedding new insight into the cellular mechanisms behind the pathogenesis and treatment of infectious diseases and cancer. Cel...
MAR 26, 2025 | 10:00 AM
C.E. CREDITS
The second webinar in the Precision Oncology Showcase series, sponsored by SOPHiA GENETICS, will highlight the successful decentralization of MSK-ACCESS® on the SOPHiA DDM™ Platfor...
MAR 12, 2025 | 8:00 PM
Liquid biopsy, a noninvasive method used for analysis of circulating biomarkers like tumor cells, DNA, and exosomes from bodily fluids, shows promise in advancing cancer research for future...
MAR 11, 2025 | 10:00 AM
C.E. CREDITS
Variant interpretation in cancer susceptibility genes presents unique challenges due to issues such as phenocopies, incomplete/age-related penetrance and the mortality associated with the ph...
MAR 07, 2025 | 1:00 PM
C.E. CREDITS
Ovarian cancer remains a significant challenge in women's health, with high mortality rates due to late-stage diagnosis. This webinar aims to provide healthcare professionals with an in-...
MAR 05, 2025 | 8:00 AM
Antibody-drug conjugates (ADCs) are a novel class of cancer therapeutics comprised of a linker-payload conjugated to a selective monoclonal antibody targeting a tumor-associated antigen (TAA...
FEB 04, 2025 | 10:00 AM
When the Precision Medicine Initiative was launched in 2015, it completely transformed patient care in oncology. Now, individual differences in genetics, environment and lifestyle, along wit...
DEC 11, 2024 | 8:00 AM
Precision Diagnosis of Ovarian Cancer – Identification of Protein Biomarkers that Separate Benign from Malignant Tumors Ovarian cancer has the highest mortality among gynecological can...
DEC 04, 2024 | 8:30 AM
Expression of co-inhibitory receptors or “checkpoint” molecules, such as CTLA-4 and PD-1, on effector T cells is a key mechanism for ensuring immune homeostasis. Dysregulated exp...
NOV 20, 2024 | 5:00 PM
C.E. CREDITS
Gastrointestinal (GI) cancers are a formidable malignancy with significant morbidity and mortality rates. Pancreatic cancer and Cholangiocarcinoma are debilitating diseases and carry poor pr...
NOV 19, 2024 | 8:00 AM
Breast cancer is a highly aggressive disease linked to poor clinical outcomes. Understanding the complex tumor microenvironment (TME) would help to identify novel therapeutic targets to impr...
NOV 14, 2024 | 12:00 PM
C.E. CREDITS
Single-cell sequencing (scSeq) is transforming disease research by revealing the intricate diversity across cell populations, uncovering crucial biomarkers and therapeutic targets often mask...
NOV 13, 2024 | 10:00 AM
C.E. CREDITS
In 2022, there were approximately 1.4 million new cases of prostate cancer reported globally and over 397,000 deaths reported globally. PSA testing can have significant value in detecting me...